U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076764
Company: MYLAN
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.025MG TABLET; ORAL Discontinued None No No
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.050MG TABLET; ORAL Discontinued None No No
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.075MG TABLET; ORAL Discontinued None No No
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.088MG TABLET; ORAL Discontinued None No No
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.1MG TABLET; ORAL Discontinued None No No
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.112MG TABLET; ORAL Discontinued None No No
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.125MG TABLET; ORAL Discontinued None No No
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.15MG TABLET; ORAL Discontinued None No No
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.175MG TABLET; ORAL Discontinued None No No
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.2MG TABLET; ORAL Discontinued None No No
LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 0.3MG TABLET; ORAL Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
06/23/2004 ORIG-1 Approval Letter (PDF)
Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/76764ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/76187ABrating.pdf
Back to Top